abstract |
The present invention relates to novel pyrazolopyridine-derived heterocyclic compounds inducing FGFR receptor dimerization of the general formula: M -LM wherein M or M, which are identical or different, each independently represent a monomeric unit M and L represents a linking group which links M and M covalently with the following monomeric unit: Their preparation process and their therapeutic application. |